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Abstract
Complex diseases and traits are likely influenced by many common and rare genetic variants and environmental factors.
Detecting disease susceptibility variants is a challenging task, especially when their frequencies are low and/or their effects
are small or moderate. We propose here a comprehensive hierarchical generalized linear model framework for
simultaneously analyzing multiple groups of rare and common variants and relevant covariates. The proposed hierarchical
generalized linear models introduce a group effect and a genetic score (i.e., a linear combination of main-effect predictors
for genetic variants) for each group of variants, and jointly they estimate the group effects and the weights of the genetic
scores. This framework includes various previous methods as special cases, and it can effectively deal with both risk and
protective variants in a group and can simultaneously estimate the cumulative contribution of multiple variants and their
relative importance. Our computational strategy is based on extending the standard procedure for fitting generalized linear
models in the statistical software R to the proposed hierarchical models, leading to the development of stable and flexible
tools. The methods are illustrated with sequence data in gene ANGPTL4 from the Dallas Heart Study. The performance of the
proposed procedures is further assessed via simulation studies. The methods are implemented in a freely available R
package BhGLM (http://www.ssg.uab.edu/bhglm/).
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Introduction
Many common human diseases and complex traits are highly
heritable and are believed to be influenced by multiple genetic and
environmental factors. Genome-wide association studies (GWAS)
represent a powerful way for discovering disease-associated factors
and investigatingthegeneticarchitectureof complex diseases[1].In
the past few years, these studies have identified hundreds of
common variants (i.e., genetic variants with minor allele frequency
(MAF) .,5%) associated with complex diseases [2]. However, the
estimated effect sizes for the identified variants are small (most odds
ratios are below 1.5) and explain only a small proportion of the
heritability of complex diseases [2,3], motivating research interest in
finding ‘missing’ genetic factors that contribute to the remaining
heritability [4,5]. Many explanations for the missing heritability
have been suggested [4,5]; one is that many common variants with
much smaller effects are yet to be detected, and another is the
possible contribution of rare variants (MAF ,0.5% or 1%) that are
poorly captured by previous GWA genotyping arrays. Empirical
studies and population genetics theory support the potentially
important role of both rare variants and common variants of very
small effects [6–10]. Several current studies have implicated
associationofrare variantswithcomplexdiseasesandtraits[11–18].
Next-generation sequencing technologies have provided unpar-
alleled tools to sequence a large number of individuals in candidate
genes, exomes, or even the entire genome, allowing for
comprehensive studies of both common and rare variants. In
addition to the common problems of handling large numbers of
variants, however, detecting disease-associated rare variants and
common variants of small effects poses unique statistical challenges
[19,20]. As such variants individually contain little variation,
statistical methods that detect association between a single variant
and disease phenotype provide low power with realistic sample
sizes. Therefore, it is necessary to develop sophisticated methods
that can effectively combine information across variants and assess
the collective effect of multiple variants [4].
Several approaches along this line have been proposed [19,20].
The basic procedure of these methods is to construct a linear
combination of multiple variants with fixed weights to summarize
the information across the variants and then estimate its
association with the phenotype [21–25]. Different weights yield
different summaries of the variants and implicate different
assumptions about the relative importance of individual variants
[24,26]. Further, they implicitly assume that all variants affect
phenotype in the same direction. However, there are many
examples in which numerous rare variants detected in a gene or
region may have disparate or even opposite effects on phenotype
[4,11]. Thus, these methods can be suboptimal if the data do not
follow the underlying assumptions. Recently, several methods have
been proposed to deal with variants with opposite effects [26–32],
and to summarize the information across variants using non-linear
functions [33,34].
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group of variants at a time. Since common diseases are likely caused
by a complex interplay among many genes and environmental
factors, however, it is more appropriate to simultaneously model
multiple groups of variants and covariates [19]. The joint analyses
would improve the power of detecting causal effects and hence lead
to increased understanding about the genetic architecture of
diseases. Such methods are also advantageous for studies involving
only one candidate gene, because numerous variants detected
within a gene can be divided into multiple groups based on their
allelic frequencies (common or rare) and functional annotations of
thegenomicregionstheyresidein(forexample,non-synonymousor
synonymous). It has been found in GWAS that the vast majority
(80%) of associated variants fall outside coding regions, emphasizing
the importance of including both coding and non-coding regions in
the search for disease-associated variants [2].
We propose here a comprehensive hierarchical generalized
linear model (GLM) framework for simultaneously analyzing
multiple groups of rare and common variants and relevant
covariates. The proposed hierarchical GLMs introduce a group
effect and a genetic score (i.e., a linear combination of main-effect
predictors for genetic variants) for each group of variants, and
jointly estimate the group effects and the weights of the genetic
scores. This framework includes various previous methods as
special cases, and can effectively deal with both risk and protective
variants in a group and can simultaneously estimate the
cumulative contribution of multiple variants and their relative
importance. The methods are illustrated with sequence data in
gene ANGPTL4 from the Dallas Heart Study, and are further
assessed via simulation studies. Finally, we conclude this article by
highlighting some areas of future research.
Methods
Hierarchical GLMs for Multiple Groups of Rare and
Common Variants
Suppose that a population-based association study consists of n
unrelated individuals, phenotyped for a continuous or discrete
disease trait and genotyped for a number of rare and/or common
genetic variants in one or multiple candidate genes or genomic
regions. The observed values of the response variable are denoted
by y=(y1, ???, yn). We assume that the genetic variants can be
divided into K groups, Gk, k=1, ???, K, and the k-th group Gk
contains Jk variants, where K$1 and Jk.1. The groups can be
constructed based on candidate genes in which the variants are
located and the types of the variants (e.g., common variants, rare
non-synonymous or synonymous coding variants). We assume that
some non-genetic variables (e.g., gender indicator, age, etc.) are
also measured for each individual and will be included as
covariates in the model to control for possible confounding effects.
We extend the hierarchical generalized linear model (GLM) of
Yi and Zhi [26] to simultaneously fit covariates and multiple
groups of rare and common variants. A generalized linear model
consists of three components: the linear predictor g, the link
function h, and the data distribution p [35,36]. The linear
predictor of individual i is expressed as the multiplicative form:
gi~
X J0
j~0
xijbjz
X K
k~1
gk
X Jk
j[Gk
ajzij
0
@
1
A ð1Þ
where b0 is the intercept, xij and bj represent covariate j and its
coefficient, respectively, zij is the main-effect predictor for
individual i at genetic variant j in group Gk, equaling to the
number of minor alleles for an additive coding (for a rare variant,
the additive coding is approximately equivalent to a dominant
coding because the frequency of the minor allele is very low), the
common coefficient gk represents the group effect for Jk variants in
the k-th group, and the individual coefficients aj can be interpreted
as the weights or relative effects of individual variants.
The common coefficient gk represents the association between
the phenotype and the linear combination
X Jk
j[Gk
ajzij of Jk individual
main-effect predictors for variants in group Gk. The linear
combination provides a way to combine the genetic variation
across the Jk individual variants, referred to as genetic score.
Therefore, the common coefficient gk represents the cumulative
importance of the Jk individual variants in the k-th group, hence
referred to as the group effect, and the weights aj, j[Gk, give the
relative importance of the individual variants in group Gk.
The mean of the response variable is related to the linear
predictor via a link function h:
E(yijgi)~h{1(gi) ð2Þ
The data distribution (likelihood) is expressed as
p(yjg,w)~ P
n
i~1
p(yijgi,w) ð3Þ
where w is a dispersion (or variance) parameter, and the
distribution p(yijgi,w) can take various forms, including Normal,
Gamma, Binomial, and Poisson distributions.
Our main goal is to estimate the group effects gk and to test the
hypotheses gk=0, k=1, ???, K. We treat the weights aj’s as
unknown parameters and estimate them along with the group
effects and other parameters from the data. But we cannot simply
use classical framework (equivalent to setting uniform distributions
on the aj’s from a Bayesian perspective), since this would result in a
nonidentifiable model [37,38]. An approach to overcoming the
problem is to use an informative prior for aj. We use the following
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aj
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aj
     s2
aj*Inv{x2 1,s2
aj
  
s2
aj
     bkj ½  *Gamma 0:5,bkj ½ 
  
p logbk ðÞ !1
ð4Þ
where the prior means mj are prefixed and will be discussed in
detail later, and the subscript k[j] indexes the group k that variant j
belongs to.
The above hierarchical prior assumes that aj follows a scale
mixture of normals with unknown variable-specific variance t2
aj.
The prior distribution for taj is a hierarchical formulation of the
half-Cauchy distribution, which has desirable properties, such as
an infinite spike at the prior mean and very heavy tails, and also
facilitates efficient computation [39,40]. An attractive feature of
our hierarchical prior is that it is free of user-chosen tuning
parameters and introduces group-specific parameters bk and
variable-specific parameters taj and saj. The group-specific
parameters provide a way to pool the information among variables
within a group and also to induce different shrinkage for different
groups, while the variable-specific parameters allow different
shrinkage for different variables. Yi and Zhi [26] set the scale
parameters saj to a known value for all the weight parameters and
recommended saj =0.5 as default. However, it would be more
reasonable to estimate the scale parameters from the data.
If the number of groups is not large, the group effects gk usually
can be estimated classically. However, low allelic frequencies can
yield very small variances for the predictors of gk, i.e.,
X Jk
j[Gk
ajzij,
and as a result the classical procedure can result in numerically
instable estimates for the group effects gk. To overcome this
problem, we can place a weakly informative prior on gk that
constrains gk to a reasonable range [41]. We use the following
hierarchical prior distribution:
gkjt2
gk*N 0,t2
gk
  
t2
gk
     s2
gk*Inv{x2 1,s2
gk
  
s2
gk*Gamma 0:5,0:5 ðÞ
ð5Þ
This hierarchical prior distribution includes group-specific param-
eters s2
gk, which can induce different shrinkage for different group
effects gk. The group-specific parameters s2
gk are assumed to follow
a weakly informative prior Gamma(0.5, 0.5). This weakly
informative prior does not strongly shrink gk towards zero, but
can constrain gk to lie in a reasonable range [41].
For the covariate effects bj,w ea l s ou s et h ea b o v ew e a k l yi n f o r -
mative prior (5), i.e., bjeN(0,t2
bj),t2
bjeInv-x2(1,s2
bj),s2
bjeGamma(0:5,
0:5).F o rt h ei n t e r c e p tb0 and the dispersion parameter w,w ec a nu s e
any reasonable non-informative prior distributions; for example,
p(b0)~N(0,t2
0) with t2
0 set to a large value, and p(logw)!1.
Model Interpretation
Our hierarchical GLMs include multiplicative parameters, a
common coefficient gk for a group of variants and a weight
parameter aj for each variant. As explained earlier, the common
coefficient gk represents the overall association of the Jk individual
variants in group k with the disease. In our hierarchical model, the
multiplicative term gk
X Jk
j[Gk
ajzij can be expressed as
X Jk
j[Gk
(gkaj)zij,
and thus the predictor zij ultimately gets the coefficient gkaj, which
represents the main effect of that variant. The coefficient gkaj is
affected by the prior mean of aj. Therefore, we define the adjusted
main effects as gk(aj{mj), which represent the effects of individual
variants.
For the multiplicative model to be useful, we need informative
prior distributions on the multiplicative parameters that allow us to
distinguish between the group effects and the individual weights.
The prior means mj and the variances t2
aj in the normal prior
distributions of the weights aj (i.e., ajeN(mj, t2
aj)) are the key
components to interpret our hierarchical model. The variances t2
aj
directly control the amount of shrinkage for aj.I ft2
aj =0, the
coefficient aj equals the prior mean mj.I ft2
aj =‘, gkaj is actually
estimated using least squares and the parameters gk and aj cannot
be distinguished. If t2
aj is finite, the coefficient aj is shrunk towards
but not identical to the prior mean mj. Therefore, the prior
distributions bridge the gap between the two extremes of simply
using the fixed weighted sum
X Jk
j[Gk
mjzij of the Jk variants as a
predictor (t2
aj =0), and including them as Jk independent
predictors (t2
aj =‘) [37,38]. This interpretation can be more
explicitly understood by the identity
gk
X Jk
j[Gk
ajzij~gk
X Jk
j[Gk
mjzijz
X Jk
j[Gk
a 
j zij
0
@
1
A ð6Þ
where a 
j ~aj{mjeN(0,t2
aj). The second term in the right side is
controlled by the variances t2
aj, and represents the deviation from
the fixed weighted sum
X Jk
j[Gk
mjzij. Most of existing methods for
analyzing rare variants proceed to construct a linear combination
(genetic score) of rare variants with fixed weights [21–25], and thus
can be viewed as special cases of our model.
The prior means mj represent the prior relative importance of
the individual variants and can be specified in various ways. The
weights proposed by previous methods [21–25] can be used as the
prior means mj in our hierarchical model. The simplest way is to
set all mj =1, resulting in the simple sum
X Jk
j[Gk
zij, and incorporating
no prior information about the relative importance of rare variants
into the model. But our method can estimate the weights from
data and produce different weights to different variants based on
their contributions to the phenotype. Therefore, our model uses a
previous score (i.e.,
X Jk
j[Gk
mjzij) as the baseline, and improves the fit
by accounting for the variation among individual variants.
An alternative choice of the prior means is to set all mj =0. With
this choice, the weights are shrunk towards zero, and variants with
small effects can be essentially removed from the model. This
seems to be reasonable, especially for the situations with non-
functional variants. However, we don’t recommend this approach
for rare variants for several reasons. First, most of rare and
common variants have small effects, but they can be cumulatively
important. In order to detect the cumulative effect, therefore, it
would be better to include all the small effects in the model.
Hierarchical GLMs for Rare and Common Variants
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accurate, if only one or a few variants are included in the model.
Third, our hierarchical model can estimate the weights of
individual variants from the data, and thus can deal with non-
functional variants and disparate effects.
Model Fitting and Inference
Our Bayesian hierarchical GLMs can be fitted using Markov
chain Monte Carlo (MCMC) algorithms that fully explore the
joint posterior distribution by alternately sampling each parameter
from its conditional posterior distribution [36]. However, it is
desirable to have a faster computation that provides a point
estimate (i.e., the posterior mode) of the coefficients and their
standard errors (and thus the p-values). Such an approximate
calculation has been routinely applied in statistical practice [41].
We develop our mode-finding algorithm by modifying the
standard iterative weighted least squares (IWLS) for fitting classical
generalized linear models [42,43].
Our algorithm updates the coefficients aj and gk using an
iterative procedure. Conditional on the current estimates ^ g gk,w e
update aj by running the generalized linear model with the
proposed prior distributions for aj and other corresponding
parameters:
gi~
X J0
j~0
xijbjz
X K
k~1
X Jk
j[Gk
^ z zijaj ð7Þ
where ^ z zij~zij^ g gk, and then conditional on the current estimates ^ a aj,
we update gk by running the generalized linear model with the
proposed prior distributions for gk and other corresponding
parameters:
gi~
X J0
j~0
xijbjz
X K
k~1
^ T Tikgk ð8Þ
where ^ T Tik~
X Jk
j[Gk
^ a ajzij. We fit these two hierarchical generalized
linear models by incorporating a flexible expectation-maximiza-
tion (EM) algorithm into the iteratively weighted least squares
(IWLS) for fitting classical generalized linear models. We describe
our EM-IWLS algorithm in detail in Text S1.
We initialize our iterative algorithm by setting the parameters
(b,a,g,w,t2,s2,b) with some plausible values. For example, we can
start with bj =0,aj =mj, gk =1,w=1,bk =0.5, saj =taj =0.5, and
sgk =tgk =sbj =tbj =1. We then update the parameters by
iteratively running the hierarchical generalized linear models (7)
and (8) until convergence. Instead of doing a nested converged
EM-IWLS for each of the two models, we can run one step of the
EM-IWLS at each iteration, thus taking less computing time to
ultimately achieve convergence by not wasting time running many
steps of the EM-IWLS within each iteration. To assess
convergence, we use the standard criterion for analysis of classical
generalized linear models (as implemented in the R function glm),
i.e., d(t){d(t{1)        = 0:1z d(t)           
ve, where d(t) is the estimate of
deviance (i.e., {2logp(yjg,w)) at the t
th iteration, and e is a small
value (say 10
25).
At convergence of the algorithm, we summarize the inferences
using the latest estimates of the coefficients (^ b b,^ a a,^ g g) and their
standard errors. Based on these outputs, we can calculate
approximate p-values as in the classical framework for testing
whether a coefficient is significantly different from zero, for
example, the hypothesis gk =0. The adjusted main effects
gk(aj{mj) are then estimated as ^ g gk(^ a aj{mj), and the approximate
standard error for ^ g gk(^ a aj{mj) can be obtained by using the delta
technique:
Var(^ g gk(^ a aj{mj))~^ g g2
kVar(^ a aj)z(^ a aj{mj)
2Var(^ g gk) ð9Þ
Therefore, we can calculate the approximate p-value for testing
the hypothesis gk(aj{mj)=0.
Implementation
Our model fitting strategy is based on extending the well-
developed IWLS algorithm for fitting classical GLMs to our
Bayesian hierarchical GLMs. The IWLS algorithm is executed in
the glm function in R (http://www.r-project.org/). We have
implemented the EM-IWLS algorithm by inserting the E-step for
updating the missing values (i.e., the variances t2
j and the
hyperparameters s2
j and bk½j ) and the steps for calculating the
augmented data and the dispersion parameter into the IWLS
procedure (see Text S1). We have created a new R function bglm
by modifying the glm function to implement our EM-IWLS
algorithm that estimates posterior modes and standard deviations
for hierarchical GLMs with the prior distributions proposed here
(see Text S1) and some other hierarchical priors [44,45]. We have
also developed an R function bglm.ex that implements the
iterative algorithm described above for fitting our hierarchical
multiplicative GLMs. Although described in the context of genetic
variants in this paper, the functions bglm and bglm.ex can be used
as general tools for routine data analysis using hierarchical GLMs.
We have incorporated the functions bglm and bglm.ex into the
freely available R package BhGLM (http://www.ssg.uab.edu/
bhglm/) that is an extensible and interactive environment for
genetic association analysis of common and rare variants and
gene-gene and gene-environment interactions.
Alternative Approaches
Our hierarchical multiplicative GLMs include various models as
special cases. Although less comprehensive, these reduced models
can be useful in some situations, and thus can be used as alternative
approaches to analysis of multiple groups of rare and common
variants. We here consider two types of reduced models. The first
ignores the group effects and directly models the main effects of
individual variants. Thus, the linear predictor (1) is reduced to
gi~
X J0
j~0
xijbjz
X K
k~1
X Jk
j[Gk
zijaj, ð10Þ
and the mean and the distribution of the response variable take the
same form of the expressions (2) and (3). In this model, the
coefficient aj represents the main effect of genetic variant j,a n d
follows the hierarchical prior distribution (4) with the prior mean
mj =0. This approach can only detect individual variants with
strong effects, and is less powerful in situations where the effects of
all individual variants are small but they are cumulatively
significant.
The second alternative approach is to preset the weights of
individual variants using the previous methods [21–25]. Thus, the
linear predictor (1) becomes
gi~
X J0
j~0
xijbjz
X K
k~1
Tikgk ð11Þ
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X Jk
j[Gk
zijmj with fixed weights mj. This model is
equivalent to setting the priors as ajjt2
ajeN(mj,t2
aj) and
t2
ajeInv-x2(z?,0) (i.e., ajeN(mj,0)) and thus is a special case of
our hierarchical model. The performance of this method heavily
depends on the quality of the fixed weights.
Results
Application: Population-Based Resequencing of ANGPTL4
and Triglycerides
Description of dataset. Romeo et al. [13] was the first
application of resequencing to a large population to examine the
role of the adipokine gene ANGPTL4 in lipid metabolism. The
study included the 3,551 participants of the Dallas Heart Study
(DHS) from whom fasting venous blood samples were obtained.
The DHS is a population-based random sample of Dallas County
residents, consisting of 601 Hispanic (H), 1,830 African American
(AA), 1,045 European American (EA) and 75 other ethnicities.
The 75 participants from other ethnicities will be excluded from
our analysis. The phenotype analyzed in our study is the log-
transformed plasma levels of triglyceride. The top panel of Figure 1
shows the histogram of this continuous phenotype and the 25th
and 75th percentiles. Following the analysis of Romeo et al. [13],
we also considered a binary trait, coding individuals in the bottom
and top quartiles of the distribution as 0 and 1, respectively, and
excluding other individuals from the analysis. Hereafter, we refer
these two phenotypes as the continuous and binary traits. Our
analyses included race (a three-level factor), age, sex, and BMI as
covariates in the model. We excluded individuals with any missing
values of the covariates from the analysis, resulting in 3008 and
1499 individuals in the analyses of the continuous and binary
traits, respectively.
Romeo et al. [13] sequenced the seven exons and the intron-
exon boundaries of the gene ANGPTL4, and identified a total of 93
sequence variations. After removing variants that were not
segregating in the sample, the numbers of variants reduced to
82 and 63 for the analyses of the continuous and binary traits,
respectively. Most of these variants were rare: only 12 and 13
variants had a minor allele frequency above 1%, and 33 and 26
variants were found only in one object in the two analyses,
respectively (see Figure 1).
The methods. We divided the variants into four groups:
common non-synonymous, common synonymous, rare non-
synonymous, and rare synonymous. We used a minor allele
frequency of 1% as the threshold to distinguish between common
Figure 1. The Dallas Heart Study data set. The top panel: the histogram of the log-transformed plasma levels of triglyceride and the 25th and
75th percentiles (the black dotted lines). The middle panel: the logarithm of the observed count of heterozygotes (Aa) and rare homozygotes (aa) for
each variant in the continuous trait analysis. The bottom panel: the logarithm of the observed count of Aa and aa for each variant in the binary trait
analysis. The gray dotted lines show the four groups: common non-synonymous, common synonymous, rare non-synonymous, and rare
synonymous.
doi:10.1371/journal.pgen.1002382.g001
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and the logarithm of the observed count of heterozygotes (Aa) and
rare homozygotes (aa) for each variant. The four groups consisted
of 2 (2), 10 (11), 26 (16) and 44 (34) variants for the analyses of the
continuous (binary) traits, respectively. Since there are only two
common non-synonymous variants (i.e., 8155_T266M and
8191_R278Q), we did not estimate their group effect and
instead treated them as two covariates in the models. We coded
the main-effect predictor of each variant using the additive genetic
model, i.e., the number of minor alleles in the observed genotype.
The genotypes of the variants contained ,3%–16% missing
values. For the missing genotypes, we filled in the variables using
the expectation of the observed values in that marker. This simple,
but reasonable, imputation method is computationally much more
efficient than comprehensive methods using MCMC algorithms or
multiple imputations and has been widely used in genetic
association studies. The previous studies and the analyses in this
work show that this imputation method yields a reasonable result
[43].
We first analyzed the data using the hierarchical multiplicative
GLMs (Equations 1–3) with the proposed hierarchical prior
distributions (Equations 4 and 5). For comparisons, we then used
three alternative methods: 1) Setting all the scale parameters saj in
the hierarchical prior (4) to a known value (e.g., 0.5). This is an
extension of Yi and Zhi [26] to multiple groups of variants; 2)
Setting the weights of individual variants to fixed values mj (see
Equation 11). This simply extends the previous Simple-Sum
[22,27] and Weighted-Sum methods [24]; 3) Ignoring the group
effects and directly estimating the main effects of all individual
variants (see Equation 10).
All the analyses simultaneously fitted all the non-genetic
variables (i.e., race, age, sex, and BMI), the two common non-
synonymous variants (i.e., 8155_T266M and 8191_R278Q) and
the three groups of variants. We used a normal regression and a
logistic regression for the continuous and the binary traits,
respectively. We set the prior means mj in two ways; the first is
to set 1 for all the variants, and the second is to set 1 for the
synonymous variants and the predicted functional scores for the
rare non-synonymous variants. The functional scores were
calculated using the software PolyPhen [24,46]. The iterative
EM-IWLS algorithm started from the plausible initial values
described earlier and took 12 (16) iterations to reach convergence
for the analysis of the continuous (binary) trait (,0.1 minutes on a
P4 desktop computer).
Results of data analyses. Figure 2 shows the results from
the analyses of the proposed hierarchical GLMs with prior means
mj set to 1 for all the grouped variants. All the non-genetic covar-
iates and the common non-synonymous variant 8191_R278Q
Figure 2. Analyses of the proposed hierarchical GLMs with prior means mj=1 for all variants. The top and bottom panels are for the
continuous and binary traits, respectively. The left panel is for the covariates, the two common non-synonymous variants and the three group effects
(G1: common synonymous; G2: rare non-synonymous; G3: rare synonymous). The right panel is for the adjusted main effects (the gray dotted line
shows the two groups G1 and G2). The points, short lines and numbers at the right side represent estimates of effects, 62 standard errors, and p-
values, respectively. Only adjusted main effects with p-value ,0.1 are labeled.
doi:10.1371/journal.pgen.1002382.g002
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binary traits. These effects were also significant under the other
models considered (see Figure 3, Figure 4 Figure 5, Figure 6).
Although not mentioned in Romeo et al. [13], our analyses
detected the minor allele of the variant 8191_R278Q to
significantly decrease triglyceride levels, consistent with the
finding of King et al. [25]. In addition to the significant non-
genetic and genetic covariates, we identified two significant group
effects, i.e., those of the common synonymous and the rare non-
synonymous variants. These two group effects remained significant
even corrected for multiple testing using the method of Benjamini
and Hochberg [47]. Our results were fairly consistent with the
original analyses; Romeo et al. [13] observed that the number of
individuals with nonsynonymous variants in the bottom quartile
was significantly greater than the number in the highest quartile,
but the number of synonymous variants in the upper and lower
tails of the distribution was identical. Since we divided
synonymous variants into two groups, our analyses produced
additional findings; the group effect of the common synonymous
variants was significant, but that of the rare synonymous variants
was insignificant.
The group effects in our model should be interpreted with
caution; a positive group effect does not necessarily mean that the
variants increase the phenotype, because for some variants the
weights can be estimated to be negative (for example, the rare
variant 1313_E40K in our analyses). The right panel of Figure 2
displays the adjusted main effects of the common synonymous and
the rare non-synonymous variants, thus showing which variants
are more important. Our analyses identified the rare variant
1313_E40K as the most important. The negative adjusted main
effect indicated that the minor allele of 1313_E40K decreases
triglyceride levels. Romeo et al. [13] and King et al. [25] also
found that the variant 1313_E40K significantly decreased
triglyceride levels. Therefore, the proposed method can simulta-
neously identify significant group effects and individual variants.
Figure 3 shows the results for the proposed hierarchical GLMs
with prior means mj set to the functional probabilities for the rare
non-synonymous variants, which were estimated to range from
0.16 to 1. These models produced qualitatively identical results as
the above analyses, but slightly lower p-values for the significant
effects. Price et al. [24] showed that incorporating computational
predictions of functional importance can increase power for
pooled association tests for rare variants.
Figure 4, Figure 5, and Figure 6 display the results from the
three alternative approaches. The models setting all the scale
parameters saj in the hierarchical prior (Equation 4) to 0.5 (as
suggested by Yi and Zhi [26]) produced results similar to the
previous analyses (Figure 4). However, this alternative method
Figure 3. Analyses of the proposed hierarchical GLMs with prior means mj being the functional probabilities for the rare non-
synonymous variants. The top and bottom panels are for the continuous and binary traits, respectively. The left panel is for the covariates, the two
common non-synonymous variants and the three group effects (G1: common synonymous; G2: rare non-synonymous; G3: rare synonymous). The
right panel is for the adjusted main effects (the gray dotted line shows the two groups G1 and G2). The points, short lines and numbers at the right
side represent estimates of effects, 62 standard errors, and p-values, respectively. Only adjusted main effects with p-value ,0.1 are labeled.
doi:10.1371/journal.pgen.1002382.g003
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The second alternative method preset the weights to 1 for all the
variants or the estimated functional probabilities for the rare non-
synonymous variants. But, these simpler models did not detect
any significant group effects (Figure 5). Our third alternative
approach simultaneously fitted the main effects of all the
covariates and common and rare variants. As expected, this
hierarchical model was able to detect only large effects. The
variants 8191_R278Q and 1313_E40K were found to have
strong effects in our previous analyses and thus were also detected
in this alternative analysis.
Simulation Studies
Simulation design. We used simulations to validate the
proposed models and algorithm and to study the properties of the
method. Although most published simulation studies of rare
variants generated genotypes assuming a population genetics
model for the propagation of rare variants, the best way will be to
take real sequence data obtained from many individuals and
simulate phenotypes based on variants in those sequences, making
assumptions only about genetic effects of variants [19]. Thus, we
performed simulation studies by taking advantage of the real
genotypes of common and rare variants and also the covariates in
the above large real dataset.
We evaluated some factors that may affect the performance of
the methods:
a) Sample size: We considered two sample sizes, including all
observations in the real data (n=3008) or individuals in the
bottom and top quartiles of the real continuous phenotype
(n=1499), respectively.
b) Number of groups and number of variants in each group: We first
considered the three groups of variants (i.e., common
synonymous, rare non-synonymous, and rare synonymous)
as in our real analyses. We then considered the second
scenario with six groups by randomly partitioning each group
into two with equal number of variants.
c) Genetic effect sizes and directions of variants: For each group of
variants, we first assumed the total heritability (h) explained
by the variants and the proportion of negative additive effects
(p.neg) for the variants. We then randomly sampled an
additive effect bj for each variant from the region [0, bh] and
changed the sign of bj with the probability p.neg. The upper
bound bh was calculated using the method of Yi and Zhi [26],
which controlled the total heritability of each group of
variants approximately equal to the assumed value h.W e
considered several combinations of different h and p.neg (see
Tables 1 and 2). The assumed total heritabilities were
Figure 4. Analyses of the hierarchical GLMs with fixed scale saj =0.5. The top and bottom panels are for the continuous and binary traits,
respectively. The left panel is for the covariates, the two common non-synonymous variants and the three group effects (G1: common synonymous;
G2: rare non-synonymous; G3: rare synonymous). The right panel is for the adjusted main effects (the gray dotted line shows the two groups G1 and
G2). The points, short lines and numbers at the right side represent estimates of effects, 62 standard errors, and p-values, respectively. Only adjusted
main effects with p-value ,0.1 are labeled.
doi:10.1371/journal.pgen.1002382.g004
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groups in our real data analyses.
We simulated a continuous and a binary phenotype. As in our
real data analyses, we simultaneously fitted all the non-genetic
variables (i.e., race, age, sex, and BMI), the two common non-
synonymous variants (i.e., 8155_T266M and 8191_R278Q) and
the grouped variants. We assumed the non-genetic coefficients and
the additive effects of 8155_T266M and 8191_R278Q to be their
estimated values in the continuous trait analysis (see the top panel
of Figure 2). Given the assumed and the simulated coefficients, we
first generated a normal continuous trait by setting the residual
standard deviation to the estimated value in the continuous trait
analysis (<0.2), and then set half of individuals with the 50%
largest continuous phenotype as ‘affected’ (yi=1) and the other
individuals as ‘unaffected’ (yi=0) to create a binary trait [26].
For each situation, 1000 replicated datasets were simulated. We
calculated the frequencies of each effect estimated as significant at
the threshold levels of a=0.05, 0.01, and 0.001 over 1000
replicates. These frequencies corresponded to the empirical power
for the simulated non-zero effects and the type I error rate for
other coefficients, respectively. We compared the proposed
method with the three alternative approaches described in the
above real data analyses. For the proposed method and the
alternative methods with fixed scale parameters or fixed weights,
we can calculate powers or type I error rates for all the covariates
and the group effects. Since the third alternative approach cannot
estimate the group effects, we simply used the minimal p-value to
calculate powers or type I error rates for each group of variants.
For each situation, the iterative EM-IWLS algorithm started from
the plausible initial values described earlier and ran until
convergence.
Results of simulations. Figure 7 and Figure 8 display the
results at the threshold level of 0.01 from simulations with three
groups and sample sizes of 3008 and 1449, respectively. Figure 9
shows the results from simulations with six groups and sample size
of 3008. In all the simulations, the non-genetic covariates (race,
age, sex, and BMI), which were highly significant in the real data
analyses, were detected with high power by all the methods (not
shown in the figures). All the methods also had high power to
detect the significant common variant 8191_R278Q, and low type
I error for the insignificant common variant 8155_T266M,
showing that the genetic effects of common variants can be
effectively estimated in large-scale studies.
In all the simulation scenarios, the proposed method and the
extension of Yi and Zhi [26] were consistently more powerful to
detect the simulated group(s) of variants than the other methods.
As expected, the power drastically increases with larger sample size
and for continuous phenotype. These relationships hold rather
generally for the methods that we examined. In the simulations
with three groups, the group of common variants was detected
with slightly higher power than the group of rare variants (see
Figure 5. Setting the weights of individual variants to fixed values mj. The top and bottom panels are for the continuous and binary traits,
and the left and right panels are for Simple-Sum and Weighted-Sum methods, respectively. The points, short lines and numbers at the right side
represent estimates of effects, 62 standard errors, and p-values, respectively.
doi:10.1371/journal.pgen.1002382.g005
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of common variants was too small, their group effect was detected
with lower power than the group of rare variants (see Figure 9a).
Our simulations showed that the proposed method and the
extension of Yi and Zhi [26] also well controlled the type I error
for groups with zero effects. This results from the fact that our
Figure 6. Ignoring the group effects and directly estimating the main effects of individual variants. The left and right panels are for the
continuous and binary traits, respectively. The points, short lines and numbers at the right side represent estimates of effects, 62 standard errors, and
p-values, respectively. Only main effects with p-value ,0.1 are labeled.
doi:10.1371/journal.pgen.1002382.g006
Table 1. Simulations with three groups.
Group 1 2 3
Number of variants 10 (11) 26 (16) 44 (34)
Scenario a h=0% h=0.5%
p.neg=0
h=0%
b h=0% h=0.7%
p.neg=0.4
h=0%
c h=0.5%
p.neg=0
h=0.5%
p.neg=0
h=0%
d h=0.7%
p.neg=0.4
h=0.7%
p.neg=0.4
h=0%
e h=0% h=0.7%
p.neg=0
h=0.7%
p.neg=0
f h=0% h=0.7%
p.neg=0.4
h=0.7%
p.neg=0.4
The number of variants in each group for simulations with n=3,008 (1,449), the
assumed total heritability (h) explained by each group of variants, and the
proportion of negative additive effects (p.neg) for groups with non-zero h.
doi:10.1371/journal.pgen.1002382.t001
Table 2. Simulations with six groups.
Group 1 2 3 4 5 6
Number of
variants
5 (5) 5 (6) 13 (8) 13 (8) 22 (17) 22 (17)
Scenario a h=0% h=0.5%
p.neg=0
h=0% h=0% h=0.5%
p.neg=0
h=0%
b h=0% h=0.7%
p.neg=0.4
h=0% h=0% h=0.7%
p.neg=0.4
h=0%
c h=0% h=0% h=0.5%
p.neg=0
h=0% h=0.5%
p.neg=0
h=0%
d h=0% h=0% h=0.7%
p.neg=0.4
h=0% h=0.7%
p.neg=0.4
h=0%
The number of variants in each group for simulations with n=3,008 (1,449), the
assumed total heritability (h) explained by each group of variants, and the
proportion of negative additive effects (p.neg) for groups with non-zero h.
doi:10.1371/journal.pgen.1002382.t002
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the prior means and thus yield the genetic score approximately
equal to the simple sum or weighted sum. Our simulations also
showed that the method ignoring group effects had the highest
type I error rate.
For the groups in which all variants affected the traits in the same
direction, the summation of the additive-effect predictors could
provide a useful genetic score of these variants, and thus the simple-
sum method had reasonable power to detect the group effect (see
Figure 7a, 7c, 7e; Figure 8a, 8c, 8e; Figure 9a, 9c). Even in this
situation, however, the proposed method and the extension of Yi
and Zhi (2011) [26] were still more powerful than the simple-sum
method.Thismayresult fromthefact thatthesehierarchicalmodels
estimate the weights from data and thus can produce different
weights for different variants based on their contributions to the
phenotype. The simulations further showed that the proposed
method had slightly higher power than Yi and Zhi (2011) [26]. This
is likely the results that the proposed method introduces variable-
specific shrinkage parameters and thus could estimate the weights of
variants more effectively. Finally, we found that the method
ignoring group effects had the lowest power. This is expected
because with the low total heritability the effects of single variants
were very small and could not be detected powerfully.
For the groups in which 60% of variants increase disease risk
and others are disease-protective, the summation of the additive-
effect predictors provides an inefficient genetic score to summarize
the information of the variants, and thus the simple-sum method
had low power to detect the association (see Figure 7b, 7d, 7f;
Figure 8b, 8d, 8f; and Figure 9b, 9d). These results are expected
because using equal weights for disease-causing and disease-
protective variants the information across variants can be
cancelled out and the true association cannot be detected.
However, the proposed method and the extension of Yi and Zhi
(2011) [26] still had reasonable power to detect these multiple rare
and common variants with opposite effects. These hierarchical
models could yield opposite weights for disease-causing and
protective variants, and thus avoid cancellation of individual-
variant variation. Once again, we found that the proposed method
had slightly higher power than Yi and Zhi (2011) [26].
Interestingly, our simulations show that the hierarchical models
of all variants were not influenced by opposite effects, because they
directly estimate the effects of individual variants; for a higher total
heritability of multiple variants, some variants had larger effects
and thus could be detectable individually.
We also evaluated power and type I error at several different
levels (e.g., a=0.05, 0.001). The conclusions described above
Figure 7. Simulations with sample size n=3,008 and three groups for the six scenarios (see Table 1). Power or Type I error rate for the
proposed method (#), Yi and Zhi (6), Simple-Sum (D) and All-Variants (+) under the threshold level of 0.01. X8155_T266M and X8191_R278Q are the
two common non-synonymous variants, and G1, G2 and G3 are the three group effects (G1: common synonymous; G2: rare non-synonymous; G3:
rare synonymous). Red and blue symbols represent results for continuous and binary traits, respectively. The dashed line is the nominal 0.01 level.
doi:10.1371/journal.pgen.1002382.g007
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hierarchical GLMs uniformly yielded much lower p-values for the
simulated group effects than the previous methods. This was also
true for the proposed method in our simulation studies. This
indicates that our method usually provides stronger evidence of
association if the variants really influence the disease.
Discussion
We have proposed here a Bayesian hierarchical generalized
linear model framework for simultaneously analyzing multiple
groups of rare and common variants and relevant covariates. Since
complex diseases and traits are likely influenced by multiple
genetic variants and environmental factors, the joint analyses of
multiple groups of genetic variants can improve the power of
detecting causal effects and lead to increased understanding about
the genetic architecture of diseases. The proposed hierarchical
generalized linear models introduce a group effect and a genetic
score for each group of variants, and jointly estimate the group
effects and the weights of the genetic scores. This can produce
‘optimal’ weights to different variants based on their contributions
to the phenotype, yielding an effective summary of the information
across variants. The simulation studies show that the proposed
method can consistently provide reasonable power even in the
presence of both risk and protective variants in a group, and has
better power than existing approaches even when all variants act
in the same direction. Application of the method to a large
published dataset on resequencing of the gene ANGPTL4 and
triglycerides not only confirmed the original findings but also
detected new associations.
In addition to the properties described above, our method has
several remarkable features. First, the proposed method can
simultaneously estimate the group effects of multiple groups of
variants and the individual effects of the variants, allowing us to
not only identify significant genes (or groups of variants) but also
assess the relative importance of single variants. Second, our
hierarchical model includes various existing methods for rare
variants as special cases. This shows that the proposed method is
theoretically more advantageous than the existing methods, and
allows us to conveniently analyze data using different ways. Third,
any external information about variants, for example, the
functional prediction, can be easily incorporated into our
hierarchical model by specifying the prior means of the weights
for variants. By doing so, our approach has the additional
advantage of accounting for uncertainties about the prior
assumptions. Fourth, our approach is based on the generalized
Figure 8. Simulations with sample size n=1,499 and three groups for the six scenarios (see Table 1). Power or Type I error rate for the
proposed method (#), Yi and Zhi (6), Simple-Sum (D) and All-Variants (+) under the threshold level of 0.01. X8155_T266M and X8191_R278Q are the
two common non-synonymous variants, and G1, G2 and G3 are the three group effects (G1: common synonymous; G2: rare non-synonymous; G3:
rare synonymous). Red and blue symbols represent results for continuous and binary traits, respectively. The dashed line is the nominal 0.01 level.
doi:10.1371/journal.pgen.1002382.g008
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continuous and discrete phenotypes and covariates, and can fit any
generalized linear models. Finally, the proposed algorithm extends
the standard procedure for fitting classical generalized linear
models in the general statistical package R to our Bayesian model,
leading to the development of stable and flexible software.
Our approach is highly extensible; we have planned several
extensions to the proposed method, some of which have been
initially implemented in our software BhGLM. The key to our
approach is the use of hierarchical prior distributions for the
weights and the group effects, so that these multiplicative
parameters are identifiable and can be simultaneously estimated
from the data. We have proposed to use the hierarchical
expression of the half-Cauchy distribution with the innovation of
introducing both group- and variable-specific parameters. The
half-Cauchy prior is an excellent default choice for many problems
[39,40], and has been shown to perform well for our purposes.
However, other hierarchical priors or penalized likelihood
methods have been developed for high-dimensional data analysis,
including lasso [48,49], adaptive Lasso [50], and the elastic net
[51]. These methods can be expressed as hierarchical models by
assigning certain priors on the variances and other hyperpara-
meters [45,48,52], and can be incorporated into our framework.
Although demonstrated with only several groups of variants, our
method can be adapted to deal with large-scale sequencing data
involving thousands of exomes or candidate genes. For these high-
dimensional settings, we need to modify the prior distributions of
the group effects and the computational algorithm. We can place a
shrinkage prior on the inverse scale in the gamma prior of s2
gk and
estimate the inverse scale from the data. We can further group the
group effects based on pathways that candidate genes belong to,
and specify the shrinkage priors by incorporating the second-level
hierarchical structure, similar to the hierarchical priors of the
weights. We describe our algorithm by simultaneously estimating
all weights. This method can be very fast when the number of
variables is not very large (say ,2000) and has the advantage of
accommodating the correlations among all the variables. Howev-
er, it can be slow or even cannot be implemented when the
number of variables is large due to memory storage and
convergence problems. We can extend the algorithm to update
coefficients group by group; at each of the iteration, the group-at-
time algorithm proceeds by cycling through all the groups of
parameters and treats the linear predictor of all other groups as an
offset in the model. This method updates coefficients in a
conditional manner, significantly reducing the number of
parameters in each M-step of the EM-IWLS algorithm, and thus
can deal with large number of variables.
Our third extension could incorporate external gene or pathway
level information into the hierarchical model. Candidate genes or
pathways studies usually consist of data at different levels, i.e.,
genetic variants within multiple candidate genes or pathways
which may be functionally related [53]. Most of statistical methods
for association studies consider only individual-level predictors
(i.e., SNPs and covariates) and ignore the hierarchical structure of
the data and gene or pathway-level information. Often, rich gene
or pathway-level information is available [54], including genomic
Figure 9. Simulations with sample size n=3,008 and six groups for the four scenarios (see Table 2). Power or Type I error rate for the
proposed method (#), Yi and Zhi (6), Simple-Sum (D) and All-Variants (+) under the threshold level of 0.01. X8155_T266M and X8191_R278Q are the
two common non-synonymous variants, and G1–G6 are the six group effects. Red and blue symbols represent results for continuous and binary traits,
respectively. The dashed line is the nominal 0.01 level.
doi:10.1371/journal.pgen.1002382.g009
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predictions of function or evolutionary conservation [55].
Therefore, there is a growing need to develop sophisticated
approaches that model the multilevel variation simultaneously and
incorporate gene or pathway-level data into the model [56,57].
Our hierarchical models provide a natural and efficient way to
incorporate the external information about candidate genes into
the analysis. One way to include the gene-level information in the
hierarchical models is to model the prior means of weights and
group effects using gene or pathway level predictors [38]. This
would allow us to pool the information in the same genes or
pathways and thus would provide more effective inference about
the genetic effects.
Our fourth extension could incorporate genetic interactions
(gene-gene and gene-environment interactions) into the model.
Just as interactions must be considered in standard GWA studies
[57–59], they are also likely to be important in association studies
involving rare variants [19]. In principle, we can extend the
proposed model to include additional groups for interactions for
each pair of groups of main effects and to define an overall effect
and a genetic score for each interaction group. However, it would
be necessary to investigate statistical power for detecting
interactions for rare variants. Finally, we have planned to extend
our method to family-based matched case-control association
studies. So far the existing methods for rare variants have focused
on population-based studies. However, for rare variants, family-
based designs may prove very useful [60]. Not only are they robust
against population stratification, but they may also offer increased
power due to the increased likelihood of affected relatives to share
the same rare disease variants. As the conditional logistic
regression commonly used for matched case-control studies can
be formulated as a Poisson regression [36], our hierarchical
generalized linear models can be applied.
The proposed hierarchical generalized linear models may
provide efficient tools for disease risk prediction and personalized
medicine. GWA studies have raised expectations for predicting
individual susceptibility to common diseases using genetic variants
[61,62]. Previous methods using only a limited number of
significant variants have typically failed to achieve satisfactory
prediction performance [63,64]. Recent studies show that joint
analysis of a large number of genetic variants can improve the
prediction of complex traits [65–67]. It is understood that a model
including as many predictors as possible and fitted appropriately
could provide better prediction. Although the previous studies
have included many genetic variants in a predictive model, they
treat these variants individually and hence could be suboptimal to
efficiently use information of genetic variants with small effects and
low frequencies. The proposed hierarchical models can better deal
with such variants and can integrate external biological knowl-
edge, and therefore may be able to improve the accuracy of
prediction.
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